A growing portfolio built around healthcare needs
Novagene has developed a diversified pharmaceutical portfolio designed to address important therapeutic requirements across multiple dosage forms. Our portfolio currently comprises 25 pharmaceutical products.
Manufactured across three dedicated blocks
Each block is dedicated and segregated, with its own utilities, controlled environment and quality control department. The dosage forms below are the DRAP-approved sections within each block.
Cephalosporin block
DRAP-approved sections within the dedicated Cephalosporin production block.
- Dry Powder Injection, Cephalosporin
- Capsule, Cephalosporin
- Dry Suspension, Cephalosporin
Penicillin block
DRAP-approved sections within the segregated Penicillin manufacturing area.
- Dry Injection, Penicillin
- Capsules, Penicillin
- Dry Suspension, Penicillin
Carbapenem block
DRAP-approved section within the dedicated Carbapenem production block.
- Dry Powder Injection, Carbapenem
Your products. Our manufacturing capabilities.
Whether you are looking to manufacture an existing product or explore new pharmaceutical opportunities, we welcome the discussion.